Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer
Clinical trial NCT05505812 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05505812
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2023-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.